Kawasaki, Japan

Mayumi Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayumi Watanabe. Retrieved from https://idiyas.com/inventor/mayumi-watanabe-jkvvaita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayumi Watanabe - Innovator in Human BCDF Purification

Introduction

Mayumi Watanabe is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of biotechnology, particularly in the purification of human BCDF. Her innovative methods have the potential to enhance pharmaceutical preparations, ensuring high purity and efficacy.

Latest Patents

Watanabe holds a patent for a method of purification of human BCDF. This patent outlines a purification process that includes an oxidation reaction and a refolding treatment of a reduced type human BCDF. The process is characterized by a gel filtration chromatographic treatment under specific guanidine hydrochloride concentrations. Additionally, her patent describes a method for obtaining a natural type human BCDF monomer by removing organic solvents and utilizing a gel filtration chromatographic column. The purification processes she developed effectively remove impurities and human BCDF analogs, resulting in a high-purity product suitable for pharmaceutical applications.

Career Highlights

Watanabe is associated with Ajinomoto Co., Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its practical applications in the pharmaceutical industry.

Collaborations

She collaborates with notable colleagues, including Daisuke Ejima and Yutaka Sato, who contribute to her research initiatives.

Conclusion

Mayumi Watanabe's innovative approaches to the purification of human BCDF represent a significant advancement in biotechnology. Her contributions are poised to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…